Solas agreements will reduce competition

by Jackie (née Heneghan) Peck | Aug 13, 2014 | Blog

Celescio have a new Solas agreement! They have pledged to work more closely with manufacturers and believe in a collaborative approach.

The deal with MSD, with produces the contraceptive Ceraxette, diabetes treatment Januvia and antihistamine Neoclarityn follows Celesio UK’s exclusive deals with manufacturers Archimedes Pharma, Ipsen and Ferring Pharaceuticals.

These agreements with manufacturers would “further reduce competition in the wholesaler market”.

← Pharmacy in the States by Eric, PHD student, USA MHRA GDP Inspectorate - Compliance with revised Good Distribution Practice →

Testimonials

“The API training course provides a good framework foundation focused on API distribution. I only wish I had found the API course much earlier, it would have saved me months of puzzling on some issues relating API importation and distribution. I am a novice when it comes to Medicinal product regulatory compliance. For months I have been rolling in the Green Guide but the Green Guide focuses mostly on Finished Form medicine, so I end up with just as many questions at the beginning, albeit … Read more

API Training

Very good overview of GDP requirements which has given me a much better understanding of client requirements for the services and products we supply. Isatec on site training – Bill Castle

GDP/RP Training

“Very Informative course. I have learnt a lot of new information and the training was given in a relaxed environment. Thank you for making the learning as interesting as possible.” Megan – Course Rating 10/10

GDP & RP Training

Informative and enjoyable. Lots of new avenues identified as resources. Thanks!

Chrissie Sharman - Caligorrx

Solas agreements will reduce competition

Recent Posts

Testimonials

Upcoming Courses

MHRA Alerts & Recalls

Get In Touch